Stuart L. Goldberg, M.D., Hematologist/oncologist at the John Theurer Cancer Center (JTCC) at Hackensack University Medical Center, specializes in the treatment of leukemia, myelodysplastic syndromes, and bone marrow failure syndromes. He has extensive experience with traditional and experimental chemotherapy approaches to these diseases, as well as stem cell transplantation options. Dr. Goldberg also serves as the chief medical officer of COTA (Cancer Outcomes Tracking and Analysis). COTA is a cloud-based data and analytics platform, developed at the JTCC, that provides physicians with data and provides three unique real-time functions: disease sorting at the highest level of clinical and molecular fidelity, outcome tracking and reporting.
I believe that readily accessible genetic information has the potential to improve public health if also accompanied by access to medical interpretation and counseling regarding test results.